{"nct_id":"NCT01848990","title":"CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2013-03","start_date_type":null,"primary_completion_date":"2014-02","primary_completion_date_type":"ACTUAL","completion_date":"2014-09","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["HALO"]}